Research Library
Curated Studies & Clinical Data
A growing library of peer-reviewed studies, clinical trial data, and systematic reviews organized by compound. Every citation is linked to its primary source.
Glucose-dependent insulinotropic polypeptide (GIP) signaling in visceral and subcutaneous adipose tissue: implications for obesity and metabolic disease-a narrative review with a structured literature search
Reviews in endocrine & metabolic disorders, 2026
How Well Are We Measuring Nausea? A Narrative Review of Patient-Reported Outcome Gaps in GLP-1 Receptor Agonist Obesity Trials
Diabetes, obesity & metabolism, 2026
Retatrutide Once Weekly for Treatment of Obstructive Sleep Apnea
The New England journal of medicine, 2026
Semaglutide modulates explore/exploit decision-making in major depressive disorder: A randomized clinical trial
Psychological medicine, 2026;56:e344
Poly(vinyl alcohol) dissolving microneedles for transdermal semaglutide delivery and anti-obesity therapy in rats
International journal of pharmaceutics, 2026;:127576
Decoding the Safety Profile of GLP-1 Receptor Agonists: Facts, Myths, and Ongoing Controversies
Current obesity reports, 2026;15(1)
Dual GIP/GLP-1 receptor agonist versus selective GLP-1 receptor agonist in patients undergoing primary total knee or hip arthroplasty
European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026;36(1)
Semaglutide Remodels the Gut Microbiome Beyond Its Appetite-Suppressing Action: Sex-Specific Gut-Brain Axis Implications
Comprehensive physiology, 2026;16(5):e70286
Emerging Therapeutic Strategies for Child and Adolescent Obesity: A Narrative Review
Nutrients, 2026;18(20)
Chronic Intermittent Hypoxia and MASLD in Obstructive Sleep Apnea: A Critical Appraisal of Mechanistic and Causal Evidence
International journal of molecular sciences, 2026;27(20)
Incretin-based therapies in psychiatry: A landscape analysis of ongoing randomized trials registered on ClinicalTrials.gov
Journal of psychiatric research, 2026;204:372-379
The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity
Annals of internal medicine;179(10):1522-1523
The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity
Annals of internal medicine;179(10):1522
The Cost-Effectiveness of Semaglutide and Tirzepatide for Patients With Knee Osteoarthritis and Obesity
Annals of internal medicine;179(10):1523-1524
Effectiveness of Weekly Semaglutide Treatment (0.5 or 1 mg) in Chilean Patients with Type 2 Diabetes Mellitus
Revista medica de Chile;154(8):1150-1159
Oral Semaglutide and the Kidney: Promise, Limitations, and the Road Ahead
Diabetes care;49(11):e210
Response to Comment on Ganeshalingam et al. Semaglutide Effects on Insulin Sensitivity and β-Cell Function in Patients With Schizophrenia, Prediabetes, and Obesity Treated With Second-Generation Antipsychotics: Findings From the HISTORI Trial, a 30-Week Randomized, Placebo-Controlled Trial With Semaglutide 1.0 mg Weekly
Diabetes care, 2026
Tirzepatide for Obstructive Sleep Apnea: Trial Evidence, Cardiometabolic Effects, and Implications for Cardiovascular Practice
Cardiology in review, 2026
Oral Versus Injectable Incretin-Based Anti-Obesity Therapies: An Integrated Computational and Evidence-Based Comparison of Orforglipron, Semaglutide, and Tirzepatide
Omics : a journal of integrative biology, 2026;:15578100261499499
GLP-1s and criminality: US trial will test whether semaglutide can fight crime
BMJ (Clinical research ed.), 2026;395:e101197